muscle weakness semaglutide impacts skeletal to a similar extent as caloric restriction in mice with diet‐induced obesity - Jeromson - The Journal of Physiology Does Semaglutide Cause Muscle Loss?

Although most studies using animal models have demonstrated neuroprotective effects, human studies have been less conclusive

All GLP-1 receptor agonists affect gut motility to some degree, with important differences in their frequency and severity of digestive side effects

Does adding levocarnitine to tirzepatide actually improve outcomes

Semaglutide is a glucagon-like peptide 1 agonist (GLP-1 agonist)

Patients experiencing significant appetite suppression and reduced caloric intake may inadvertently develop nutritional deficiencies, including inadequate protein intake, vitamin D deficiency, or insufficient calcium consumption